Key result
In hospitalized patients with HFpEF, moderate or greater oedema did not significantly increase the rate of 60-day rehospitalization or death compared to mild or no oedema (HR 1.44; 95% CI 0.87-2.39; P=0.156).
Why the study?
HFpEF is a heterogeneous condition where tissue congestion manifested by oedema is not present in all patients, prompting comparison of clinical characteristics, exercise capacity, and outcomes.
Does the presence of peripheral oedema affect clinical characteristics, exercise capacity, and outcomes in patients with HFpEF?
Population
393 ambulatory and 338 hospitalized HFpEF patients with LVEF ≥50%
Comparison
Patients with oedema vs without oedema
Authors
Loading...
Moderate oedema does not predict 60-day events in hospitalized HFpEF; hypothesis-generating and should not yet guide discharge decisions.
Observational (n=731)
Yes
Does the presence of peripheral oedema affect clinical characteristics, exercise capacity, and outcomes in patients with HFpEF?
Hazard Ratio: 1.44 (95% CI 0.87–2.39)
p-value: p=0.156
In patients with HFpEF, peripheral oedema is associated with higher BMI, more comorbidities, and worse exercise intolerance, but does not significantly alter short-term clinical outcomes or treatment response.
Fudim et al. (2020) conducted an observational in Heart failure with preserved ejection fraction (HFpEF) (n=731). Oedema vs. Without oedema (or mild/none) was evaluated on 60 day rehospitalization/death (HR 1.44, 95% CI 0.87-2.39, p=0.156). In hospitalized patients with HFpEF, moderate or greater oedema did not significantly increase the rate of 60-day rehospitalization or death compared to mild or no oedema (HR 1.44; 95% CI 0.87-2.39; P=0.156).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: